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by severe pulmonary disease, includ-
ing pleural effusions. Clinicians
worldwide should be mindful that
melioidosis in tsunami survivors may
appear many years after exposure.
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Chytrid Fungus in
Europe 
To the Editor: Amphibian species
are declining at an alarming rate on a
global scale (1). One of the major rea-
sons for these declines is chytrid-
iomycosis, caused by the chytrid-
iomycete fungus, Batrachochytrium
dendrobatidis (1,2). This pathogen of
amphibians has recently emerged
globally (2,3) and has caused mass
die-offs and extensive species
declines on 4 continents (1,3); knowl-
edge of its distribution and effects on
amphibian populations remains poor.
In Europe, little is known about B.
dendrobatidis distribution, which is
disturbing when one considers that at
least 3 European amphibian species
are undergoing chytrid-associated
die-offs that will likely lead to local
extinction (4,5) (J. Bosch et al.,
unpub. data).
We screened 1,664 current and
archived samples of wild amphibians
collected in Europe from 1994 to
2004 by researchers using amphibians
as study organisms. B. dendrobatidis
infects the skin of adult amphibians
and the mouthparts of anuran larvae;
samples included toe clippings and
skin samples from adults and mouth-
parts of tadpoles. Our sampling was
opportunistic, including both caudates
and anurans. We screened all samples
for chytrid fungus with quantitative
real-time polymerase chain reaction
(PCR) of the ITS-1/5.8S ribosomal
DNA region of B. dendrobatidis (6),
including appropriate positive and
negative controls. We confirmed real-
time PCR positives by amplifying a
subset of these positives with a sec-
ond  B. dendrobatidis–specific PCR
with a nested reaction developed from
the ctsyn1 locus (3). To confirm that
detection with real-time PCR indicat-
ed a viable chytrid infection, when
actual tissue samples were available,
we examined a generous subset using
histologic features for typical signals
of pathogenic B. dendrobatidis infec-
tion. Specifically, we found intracel-
lular zoospore-carrying sporangia
within the stratum corneum and stra-
tum granulosum of toe and skin sam-
ples. We also compared real-time
PCR amplification profiles of sus-
pected positives to those generated
from samples from animals involved
in chytrid-driven die-offs and found
these results to be comparable.
Furthermore, attempts to isolate the
fungus from dead animals were suc-
cessful when animals were obtained
in a suitable condition for this purpose
(see below).
Our survey found B. dendrobatidis
in amphibians in 5 European coun-
tries, Spain, Portugal, Italy,
Switzerland, and Great Britain.
Previously, chytrid infection has been
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reported in wild amphibians only in
Spain, Germany, and Italy (4,5,7,8).
We detected chytrid fungus in 20 of
28 amphibian species examined, rep-
resenting 9 different genera, 5 anu-
ran, and 4 caudate, in 6 families. We
found signs of chytrid in archived
samples from as early as 1998. The
number of infections per country we
found were Austria 0/24, Croatia 0/8,
Czech Republic 0/18, Italy 2/101,
France 0/60, Germany 0/51, Greece
0/88, Portugal 1/25, Slovenia 0/29,
Spain 108/345, Sweden 0/197,
Switzerland 63/252, and United
Kingdom 2/466. Infection prevalence
was exceptionally high in Spain and
Switzerland. In Spain, ongoing
chytridiomycosis-driven declines of
midwife toads (Alytes obstetricans)
and salamanders (Salamandra sala-
mandra) have been documented since
1997 (4) and 1999 (5), respectively,
and confirmed with scanning electron
microscopy, histologic examination,
and molecular detection methods
(4,5). Common toads have been suf-
fering apparently minor chytrid-relat-
ed die-offs in Spain for several years,
but mass die-offs were observed in
2004 (5) (J. Bosch et al., unpub.
data). No chytrid-related die-offs
have been reported in Switzerland.
Furthermore, the infected animals
from Switzerland were all adults in
good breeding condition, many of
which reproduced successfully in
behavioral and ecologic experiments.
Real-time PCR amplification profiles
for the Swiss samples were quantita-
tively equivalent to those generated
from samples of A. obstetricans col-
lected during mass die-off events in
Spain; from these latter samples, we
successfully isolated viable B. den-
drobatidis cultures from 2 geographi-
cally distinct areas. In Great Britain,
we found chytrid in 2 of 14 intro-
duced North American bullfrogs
(Rana catesbeiana) caught in 2004
but did not find it in wild-captured
native British species. Examination
by microscope and electron micro-
scope of 180 native British amphib-
ians from 1992 to 1996 did not find
chytrid infection (A.A. Cunningham,
unpub.data). The ability of the North
American bullfrog to act as a vector
for chytrid range expansion has been
hypothesized (9,10). Our data may
indicate that bullfrogs can fulfill this
role in Great Britain and other areas;
we have found the molecular signal
of chytrid infection from introduced
North American bullfrogs collected
on 3 separate continents (T.W.J.
Garner et al., unpub. data).
This survey shows that B. dendro-
batidis is widely and irregularly dis-
tributed in Europe and infects a broad
range of amphibian species.
Furthermore, because of the oppor-
tunistic nature of our sampling strate-
gy, our results certainly underestimate
the overall prevalence of B. dendroba-
tidis  in Europe. These findings are
surprising considering that chytrid-
related die-offs have been infrequent-
ly described in Europe. This may be
because  B. dendrobatidis has only
recently and rapidly expanded its
range into Europe (3), and the conse-
quences are only now being detected
in wild amphibian populations;
because the expression of chytrid-
iomycosis is environmentally limited
(11); or because European amphibians
exhibit highly variable levels of
resistance to chytrid infection.
Notwithstanding, our knowledge of
the epidemiology of B. dendrobatidis
is insufficient to effectively manage
wildlife and conduct disease abate-
ment. As data regarding the distribu-
tion of chytrid fungus accumulate and
the ecologic requirements for disease
persistence and transmission are iden-
tified (11), management of the
pathogen can become more predic-
tive. Basic management practices,
such as restricting transportation of
potential carriers and restricting pet
trading and reintroduction projects,
coupled with field monitoring, must
be improved to prevent further global
emergence of this pathogen. Our
results also show that asymptomatic
amphibians must be included in any
broad-scale epidemiologic screening
for this emergent pathogen.
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To the Editor: Vibrio metschni-
kovii is a gram-negative, oxidase-neg-
ative bacillus. This species was isolat-
ed in 1981 from blood culture of an
82-year-old diabetic woman with
cholecystitis (1). It was previously
isolated from river water, clams, oys-
ters (2), fish (3), and birds that died of
a choleralike illness (4). We report
isolation of V. metschnikovii in
bronchial aspirate from a patient with
pneumonia.
A63-year-old man was admitted to
the intensive care unit (ICU) of A.
Calmette hospital in Lille, France, for
acute respiratory failure related to
community-acquired pneumonia. The
patient had a history of chronic
obstructive pulmonary disease with a
forced expiratory volume of 820 mL
in 1 s (32% of predictive value); he
was treated with oral salmeterol,
terbutaline, and prednisolone (40
mg/day). He was HIV negative. On
ICU admission, he had the following
values: respiratory rate 30/min, tem-
perature 39°C, pulse rate 140/min,
blood pressure 140/90 mm Hg,
Glasgow coma score 15, leukocyte
count 13.7 × 109/L, hemoglobin level
10.2 g/dL, procalcitonin level 22
ng/mL, and C-reactive protein level
73 mg/L. A chest radiograph showed
diffuse bilateral infiltrates. Analysis
of arterial blood gases with 6Lof oxy-
gen/min showed respiratory acidosis:
pH 7.30, pCO2 59 mm Hg, pO2 78
mm Hg, HCO3 23 mmol/L, O2 satura-
tion 94%. Other laboratory test results
were normal. After noninvasive venti-
lation failed, the patient was immedi-
ately intubated and mechanically
ventilated.
Blood cultures and bronchial aspi-
rate samples were obtained before ini-
tiating treatment with antimicrobial
drugs. The patient was treated with
amoxicillin/clavulanic acid and
ciprofloxacin. Blood cultures showed
negative results. Microscopic exami-
nation of the bronchial aspirate
showed no squamous epithelial cells,
a few gram-negative bacilli, leuko-
cytes, and many ciliated bronchial
cells. The presence of ciliated cells
was the best indicator that secretions
originated from the lower respiratory
tract. A urinary antigenic test result
for  Legionella spp. was negative.
Quantitative culture of the bronchial
aspirate on bromocresol purple agar,
blood agar (grown in an atmosphere
of 5% CO2), and chocolate agar plates
yielded  V. metschnikovii (107
CFU/mL) and nonhemolytic strepto-
cocci (105 CFU/mL) as the oropha-
ryngeal flora. These streptococci
(gram-positive, catalase-negative)
were not considered to be the patho-
genic agent.
The strain of V. metschnikovii iso-
lated was a gram-negative, curved
rod. This facultative aeroanaerobic
bacillus formed opaque colonies
(diameter 3 mm) on blood agar in 24
h and showed complete hemolysis. It
was catalase positive, oxidase nega-
tive, and did not reduce nitrate to
nitrite. This strain was identified as V.
metschnikovii with an ID GBN Vitek
2 card (bioMérieux, Marcy l’Etoile,
France) (acceptable T identification
index 0.22). Confirmation was done
with a Microseq 500 16S ribosomal
DNA bacterial kit (PE Applied
Biosystems, Foster City, CA, USA).
A 475-bp fragment was sequenced in
an automated sequencer (360 ABI
Prism, PE Applied Biosystems). The
fragment was compared with National
Center for Biotechnology Information
(Bethesda, MD, USA) GenBank
entries and showed 99% homology
with  V. metschnikovii (GenBank
accession no. X74712.1). In vitro sus-
ceptibility testing with the AST-N032
Vitek 2 card (bioMérieux) showed
that the organism was resistant to
ampicillin, ticarcillin, piperacillin,
and aminoglycosides.
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